Suppr超能文献

肿瘤坏死因子受体相关因子6(TRAF6)与肿瘤的关系。

The relationship between TRAF6 and tumors.

作者信息

Li Jiaoduan, Liu Nian, Tang Ling, Yan Bei, Chen Xiang, Zhang Jianglin, Peng Cong

机构信息

Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan China.

出版信息

Cancer Cell Int. 2020 Sep 3;20:429. doi: 10.1186/s12935-020-01517-z. eCollection 2020.

Abstract

Tumor necrosis factor receptor (TNFR)-related factors (TRAFs) are important linker molecules in the tumor necrosis factor superfamily (TNFSF) and the Toll-like/interleukin-1 receptor (TLR/ILR) superfamily. There are seven members: TRAF1-TRAF7, among those members, tumor necrosis factor receptor-associated factor 6 (TRAF6) is upregulated in various tumors, which has been related to tumorigenesis and development. With the in-depth study of the relationship between TRAF6 and different types of tumors, has oncogenic characteristics involved in tumorigenesis, tumor development, invasion, and metastasis through various signaling pathways, therefore, targeting TRAF6 has provided a novel strategy for tumor treatment. This review summarizes and analyzes the role of TRAF6 in tumorigenesis and tumor development in combination with the current research on TRAF6 and tumors.

摘要

肿瘤坏死因子受体(TNFR)相关因子(TRAFs)是肿瘤坏死因子超家族(TNFSF)和Toll样/白细胞介素-1受体(TLR/ILR)超家族中的重要衔接分子。共有七个成员:TRAF1 - TRAF7,在这些成员中,肿瘤坏死因子受体相关因子6(TRAF6)在各种肿瘤中上调,这与肿瘤的发生和发展有关。随着对TRAF6与不同类型肿瘤之间关系的深入研究,其通过各种信号通路在肿瘤发生、肿瘤发展、侵袭和转移中具有致癌特性,因此,靶向TRAF6为肿瘤治疗提供了一种新策略。本文结合目前关于TRAF6与肿瘤的研究,总结并分析了TRAF6在肿瘤发生和肿瘤发展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b978/7469280/f5d53308a0a6/12935_2020_1517_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验